NK cell and DC interactions

Trends in Immunology

Volumn 25, Issue 1, 2004, Pages 47-52

  Cooper, Megan A ^a   Fehniger, Todd A ^b   Fuchs, Anja ^b   Colonna, Marco ^b   Caligiuri, Michael A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CD94 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

BONE MARROW TRANSPLANTATION; CELL INTERACTION; CELL MATURATION; CELL SUBPOPULATION; CELL TYPE; CYTOKINE PRODUCTION; CYTOLYSIS; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; NATURAL KILLER CELL; NONHUMAN; REVIEW;

EID: 0347592866     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2003.10.012     Document Type: Review

References (43)

1. Cooper M.A., et al. The biology of human natural killer-cell subsets. Trends Immunol. 22:2001;633-640.
2. Campbell K.S., Colonna M. Human natural killer cell receptors and signal transduction. Int. Rev. Immunol. 20:2001;333-370.
3. Moretta A., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:2001;197-223.
4. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 101:2003;3052-3057.
5. Fehniger T.A., Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood. 97:2001;14-32.
6. Pulendran B., et al. Sensing pathogens and tuning immune responses. Science. 293:2001;253-256.
7. Palucka K., Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol. 14:2002;420-431.
8. Fernandez N.C., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:1999;405-411.
9. Andrews D.M., et al. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4:2003;175-181.
10. Osada T., et al. Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function. Cell. Immunol. 213:2001;14-23.
11. + cell-derived NK cell cytotoxicity by dendritic cells. J. Immunol. 166:2001;1590-1600.
12. Gerosa F., et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:2002;327-333.
13. Piccioli D., et al. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:2002;335-341.
14. Ferlazzo G., et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:2002;343-351.
15. Wilson J.L., et al. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163:1999;6365-6370.
16. Carbone E., et al. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29:1999;4022-4029.
17. Chiesa M.D., et al. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33:2003;1657-1666.
18. Ruggeri L., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 295:2002;2097-2100.
19. Velardi A., et al. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 23:2002;438-444.
20. Miller G., et al. Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity. FASEB J. 17:2003;728-730.
21. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2:2002;957-964.
22. Lande R., et al. IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of cxcl10: selective recruitment of NK and activated T cells. J. Immunol. 170:2003;1174-1182.
23. Buentke E., et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J. Invest. Dermatol. 119:2002;850-857.
24. Pardoll D.M. Immunology. Stress, NK receptors, and immune surveillance. Science. 294:2001;534-536.
25. Ferlazzo G., et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33:2003;306-313.
26. dim natural killer cell subsets. J. Immunol. 161:1998;400-408.
27. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166:2001;6477-6482.
28. Cooper M.A., et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood. 100:2002;3633-3638.
29. Waldmann T., et al. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:1998;205-226.
30. Mattei F., et al. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:2001;1179-1187.
31. Dubois S., et al. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity. 17:2002;537-547.
32. Valteau-Couanet D., et al. Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients. Blood. 100:2002;2554-2561.
33. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:2003;133-146.
34. Vitale M., et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:1998;2065-2072.
35. Mailliard R.B., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171:2003;2366-2373.
36. Colonna M., et al. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14:2002;373-379.
37. Dallal R.M., Lotze M.T. The dendritic cell and human cancer vaccines. Curr. Opin. Immunol. 12:2000;583-588.
38. Jefford M., et al. The use of dendritic cells in cancer therapy. Lancet Oncol. 2:2001;343-353.
39. Fehniger T.A., Caligiuri M.A. Ontogeny and expansion of human natural killer cells: clinical implications. Int. Rev. Immunol. 20:2001;503-534.
40. Farag S.S., et al. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood. 100:2002;1935-1947.
41. Lanier L.L., et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136:1986;4480-4486.
42. Smith K.A. Interleukin-2: inception, impact, and implications. Science. 240:1988;1169-1176.
43. Granucci F., et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:2001;882-888.